The higher ApoB/ApoA1 ratio seen in our study of patients in late CKD compared to early CKD, is relevant given the magnified cardiovascular risk associated with progressive diabetes-associated CKD (18). This evidence concerns the gene APOA1 and diabetes mellitus.